|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.080 USD | -72.53% |
|
-72.53% | -48.74% |
| 06-10 | B. Riley Initiates Elicio Therapeutics at Buy With $27 Price Target | MT |
| 06-01 | Elicio Therapeutics, Inc. Publishes Preclinical Data On AMP-DNA Adjuvant Technology In Science Advances | CI |
| Market Cap | 70.82M 61.75M 57.19M 53.54M 100M 6.68B 101M 678M 263M 3.29B 266M 260M 11.42B | P/E 2026 * |
-1.78x | P/E 2027 * | -1.46x |
|---|---|---|---|---|---|
| Enterprise Value | 70.82M 61.75M 57.19M 53.54M 100M 6.68B 101M 678M 263M 3.29B 266M 260M 11.42B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
70.18% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -72.53% | ||
| 1 week | -72.53% | ||
| Current month | -64.34% | ||
| 1 month | -55.51% | ||
| 3 months | -65.94% | ||
| 6 months | -48.61% | ||
| Current year | -48.74% |
| 1 week | 2.66 |  | 6.64 |
| 1 month | 2.66 | | 16 |
| Current year | 2.66 | | 16 |
| 1 year | 2.66 | | 16 |
| 3 years | 2.66 | | 16 |
| 5 years | 2.66 | | 24.39 |
| 10 years | 2.66 | | 24.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Connelly
CEO | Chief Executive Officer | 66 | 2018-09-30 |
Preetam Shah
DFI | Director of Finance/CFO | 54 | 2025-03-23 |
Esther Welkowsky
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Connelly
BRD | Director/Board Member | 66 | 2018-09-30 |
Jay Venkatesan
BRD | Director/Board Member | 54 | 2023-05-31 |
Julian Adams
CHM | Chairman | 71 | 2016-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02-01 | Free | Chief Executive Officer | 220,800 | 1.2625% | ||
| 02-01 | Free | Chief Financial Officer | 71,900 | 0.4111% | ||
| 02-01 | Free | Chief Technology Officer | 62,400 | 0.3568% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -72.53% | -72.53% | -48.74% | -65.83% | 70.82M | |
| +1.44% | +1.71% | -10.63% | -9.16% | 43.13B | |
| +3.31% | +5.93% | +308.19% | +562.02% | 34.65B | |
| +2.84% | +2.14% | +6.87% | +34.93% | 30.03B | |
| -1.70% | -7.54% | +8.51% | -22.34% | 28B | |
| -1.90% | -1.56% | +11.62% | +19.80% | 24.45B | |
| -0.14% | +5.86% | - | - | 14.34B | |
| +0.68% | -1.53% | +52.04% | +107.47% | 13.14B | |
| -0.57% | -2.43% | +5.18% | +4.20% | 12.53B | |
| -0.26% | +1.15% | +100.27% | +80.69% | 12.25B | |
| Average | -6.88% | -6.47% | +48.15% | +79.09% | 21.26B | |
| Weighted average by Cap. | +0.75% | +1.25% | +65.18% | +113.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -43.68M -38.08M -35.27M -33.02M -61.92M -4.12B -62.29M -418M -162M -2.03B -164M -160M -7.04B | -57.53M -50.16M -46.46M -43.49M -81.57M -5.43B -82.06M -551M -214M -2.67B -216M -211M -9.28B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-18 | 3.850 $ | -18.26% | 5,435,699 |
| 26-06-17 | 4.710 $ | +70.65% | 51,120,414 |
| 26-06-16 | 2.760 $ | -32.35% | 4,871,359 |
| 26-06-15 | 4.080 $ | -72.53% | 8,464,282 |
| 26-06-12 | 14.85 $ | +6.53% | 125,444 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ELTX Stock
Select your edition
All financial news and data tailored to specific country editions
